Business Wire

Metap Inc.: Metaverse Project GensoKishi Online Announces a Closed Alpha Ticket (Bronze) Lottery

Share

GensoKishi Online -Meta World- is developed under the license of the well-known Japanese 3D MMO title “Elemental Knights Online.” The iconic game has a 14 year history and has accumulated a total of 8 million downloads worldwide. It already has a 3D MMORPG game with active users, with a fully-functioning 3D metaverse, that simultaneously connects users from around the world, be it smartphones, PCs, or video game consoles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005812/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

GensoKishi Closed Alpha test (Graphic: Business Wire)

The game recently announced its collaboration with gaming legend Yoshitaka Amano to design their NFT collection.

Since the release of the GensoKishi website and various social media channels on December 2, 2021, GensoKishi have achieved a number of records to date. The governance token of the GensoKishi is currently more than 50 times higher than the initial listing price of Bybit, the first exchange to list MV token.

GensoKishi Online have opened up applications to enter the lottery for the Closed Alpha Bronze Tickets. Winners of the lottery will be provided exclusive access to GensoKishi’s Closed Alpha Test.

Click here to read details about Closed Alpha Test

Click here to visit the GensoKishi Online Metaworld Official Website

Campaign details regarding the Closed Alpha Testing Period

All participants of the Closed Alpha will receive a limited edition NFT to commemorate their participation in the Testing Period.

During the Closed Alpha Testing Period, an item called the "Alpha Hunter's Certificate" will drop at a certain probability rate when players defeat monsters during gameplay.

Each "Alpha Hunter's Certificate" will be treated as 1 point, and at the end of the first half and the second half of the Closed Alpha Testing Period, a ranking will be generated based on the number of “Alpha Hunter's Certificate” collected. The top 10 players of this rank will receive a limited edition NFT (equivalent to SR), and the top 11 to 100 players will receive a limited edition NFT (equivalent to SR).

How do you apply for the Closed Alpha Bronze Ticket lottery?

Please complete the tasks listed in here and submit your application via the application form.

Application Period for the Closed Alpha Bronze Ticket

  • Start Date: May 3, 2022 12:00 (GMT+8)
  • End Date: May 17, 2022 23:59 (GMT+8)
  • Scheduled date of ticket distribution to winners: May 27, 2022

*Please note that applications cannot be accepted after the end date of the application period.
*Please note that the ticket distribution date is subject to change.

Closed Alpha Period

The specific schedule will be announced at a later date.

Apply now from here

*Check out the GensoKishi White Paper:
https://genso.game/pdf/WhitePaper_genso_EN.pdf

GensoKishi Online -META WORLD- Community

Official Site : https://genso.game/
Twitter: https://twitter.com/genso_meta
Discord: https://discord.gg/gensometa
Telegram: https://t.me/gensometamain
YouTube: https://www.youtube.com/channel/UCMi4wGMEWgC9VVps8d_NLDA

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Metap Inc.
Maxi Kuan
Phone number: +886935312638
E-mail address: info@genso.game

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Starr Insurance Companies Expands in Thailand17.5.2022 22:33:00 CEST | Press release

Starr Insurance Companies (Starr) announced an agreement with FPG Insurance Holdings Limited (HK) (FPG) and local Thai shareholders to purchase FPG Insurance Public Company Limited (FPG Thailand), a Thai non-life insurance company, together with local Thai parties. Starr’s investment will be held by its Bermuda insurance company, Starr Insurance & Reinsurance Limited. The transaction is expected to close in the second quarter of 2022, subject to certain customary closing conditions, including any necessary regulatory approvals. “Thailand is an important, fast-growing insurance market — one of the cornerstones of the Southeast Asia economy,” said Maurice R. Greenberg, Starr’s Chairman & CEO. “Asia is both commercially and culturally important to Starr, as we trace our roots to an American-owned company founded in Shanghai more than 100 years ago. We look forward to serving the needs of local Thai companies and consumers through this new insurance capability.” David Zuellig, FPG regional

Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE -related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting17.5.2022 22:15:00 CEST | Press release

Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) held May 16-19, 2022, in Washington, D.C. Emendo presented pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, demonstrating the power of Emendo’s dual technology platforms that enable the development of a highly specific editing composition that demonstrates no off-targets and complete allele specificity. Significantly, the lack of off-target achieved by Emendo’s engineered and optimized OMNI nuclease also eliminated any translocations. Edited patient derived CD34+ cells differentiated normally into neutrophils both in-vitro and in-vivo, showing full engraftment and reconstitution of all blood lineages, as required for the desired therapeutic effect. “ELANE-based

Piper Sandler Advises PETRONAS Chemicals Group Berhad on Acquisition of Perstorp17.5.2022 19:59:00 CEST | Press release

Piper Sandler & Co. chemicals investment banking announced today that it has advised PETRONAS Chemicals Group Berhad (PCG) on its acquisition of Perstorp Holding AB. The transaction Enterprise Value is €2,300 million and base purchase price, less adjusted net debt, is €1,538 million. It is expected to close in Q3 2022 subject to customary closing conditions. PCG is the leading integrated chemicals producer in Malaysia and one of the largest in Southeast Asia. It operates a number of world-class production sites, which are fully vertically integrated from feedstock to downstream end-products. With a total combined production capacity of 12.8 million metric tons per annum (mtpa), it is involved primarily in manufacturing, marketing, and selling a diversified range of chemical products, including olefins, polymers, fertilizers, methanol and other basic chemicals and derivative products. Listed on Bursa Malaysia in 2010 and with more than three decades of experience in the chemicals indust

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods17.5.2022 19:53:00 CEST | Press release

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11th May 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005112/en/ Morinaga Milk obtains the registration of "New Food Ingredient" in China for use of its probiotic Bifidobacterium longum BB536 in infant and toddler foods on 11th May 2022. (Graphic: Business Wire) Following a complex and lengthy registration process, the probiotic strain B. longum BB536 meets the highest standards of safety and regulatory compliance and has now completed the approval process for use as an ingredient in infant and toddler milk and food products for children under three years old in China. “We are extr

Hiro Capital Joins Knollwood and Boost VC With Major Investment in Skybound Entertainment17.5.2022 19:30:00 CEST | Press release

Hiro Capital has invested in Skybound Entertainment in a significant, undisclosed round led by Knollwood Advisory with participation from Boost VC, and follow-on participation from Com2uS and Skydance Entertainment. Skybound Entertainment is home to acclaimed franchises including The Walking Dead, Invincible, and Impact Winter. “There is nothing more powerful than storytelling, and I’m delighted that Hiro has been able to invest in Skybound Entertainment, creators and curators of extremely compelling omniverses,” said Sir Ian Livingstone, Co-Founding Partner of Hiro Capital. “Hiro’s trust in our vision will help us accelerate the evolution of existing hit franchises as well as new content for our fan base around the world,” said Skybound CEO David Alpert. Skybound brings together creators across its multi-faceted business, including comics, interactive games, audio, film, and television (traditional and digital platforms), licensing, and merchandising. Skybound has successfully franchi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom